ATAI News and Press, ATAI Life Sciences N.V. From 08/22/23

2023-08-22 12:50:11 ET More on psychedelic drug companies Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets. COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down Psychedelic Stocks: Don't Bet On Just 1 Company Seelos:...

The American Psychedelic Practitioners Association (APPA) and nonprofit BrainFutures have teamed up to publish the first-ever guidelines for psychedelic-assisted therapists. These new guidelines will establish standards for the relatively new field of psychedelic-assisted therapy as the segment...

2023-08-10 11:01:09 ET ATAI Life Sciences press release ( NASDAQ: ATAI ): Q2 GAAP EPS of -$0.21 in-line. Cash, cash equivalents and short-term investments totaled $227.5 million as of June 30, 2023, compared to $273.1 million as of December 31, 2022. For further deta...

Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients with Cognitive Impairment Associated with Schizophrenia DMX-1002 (Ibogaine) Phase 1 results enable discussions with regulatory authorities to assess progressing into proof...

NEW YORK and BERLIN, Aug. 08, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced results from Perception Neuroscience’s Phase 1 intravenou...

Researchers from the University of Zurich Psychiatric Hospital are comparing what happens to the human brain during meditation and hypnosis, as well as while under the effects of psychedelics. Brain changes while under the influence of drugs or during states such as hypnosis and meditation ha...

American researchers studying the effects of psychedelics on eating disorders have found that psilocybin, the main hallucinogenic agent in magic mushrooms, may be able to treat anorexia. U.S. researchers ran the small study,  which involved 10 adult women aged 18 to 40 years of age. Eat...

Research into psychedelics is increasingly revealing that these purportedly dangerous drugs may have potent mental health benefits . While modern antidepressants work by influencing the levels of hormones such as serotonin in the brain, psychedelics seem to deliver their benefits by influencin...

2023-07-16 18:00:00 ET Summary Alex Carchidi returns to update investors on the psychedelics industry. Collapse, consolidation, and why you shouldn't bet on just 1 stock. Compass Pathways' timeline for clinical trials; Atai and Cybin's recent wins. Alex Carchidi For ...

2023-07-15 04:25:01 ET Summary The memo reads that the bear market has been cancelled, and there are few who are as happy about the change in fortunes as Cathie Wood and ARK Funds. Her flagship ARKK fund, as well as other ARK family funds, have had an impressive run lately and wer...